Loading…
Loading…

| MRK | Merck & Co., Inc. | $150.34 | $371.3B |
| NVS | Novartis AG | $159.99 | $304.1B |
| NVO | Novo Nordisk A/S | $46.60 | $206.9B |
| GILD | Gilead Sciences, Inc. | $151.00 | $187.5B |
| PFE | Pfizer Inc. | $28.45 | $162.1B |
| DHR | Danaher Corporation | $207.66 | $146.0B |
| BMY | Bristol-Myers Squibb Company | $66.82 | $136.5B |
| SNY | Sanofi | $44.24 | $106.2B |
| GSK | GSK plc | $49.89 | $100.0B |
| BSX | Boston Scientific Corporation | $47.80 | $71.0B |